YouScript Wins "Genomics Innovation Award" in 8th Annual MedTech Breakthrough Awards Program

Verisense Health Elects Josh Tolkoff to its Board of Directors

Josh brings extensive medical device, investment, and growth management experience to his new role.

Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health's Advisory Board

https://www.prnewswire.com/news-releases/dr-tim-garnett-former-chief-medical-officer-of-eli-lilly-joins-lindus-healths-advisory-board-302127131.html?tc=eml_cleartime

PumasAI Named Best Clinical Pharmacology Technology Development Firm in Biotechnology Awards

AppOmni Releases Zero Trust Posture Management, Enhancing SaaS Security by Extending Zero Trust to the Application Layer

AppOmni, the pioneer of SaaS security posture management (SSPM), today formally announced AppOmni Zero Trust Posture Management (ZTPM), a unique solution set that dramatically strengthens security in modern infrastructures by bridging a critical gap in network-centric Zero Trust (ZT) architectures.

Alfa Chemistry Rolls Out Various Nucleic Acid Delivery Options for Nucleotide Vaccine Research

CD Formulation Unveils Hydrogel Microneedle Patch Technology to Increase Drug Loading Capacity

Sun Pharmaceuticals Industries Ltd announced the acquisition of Concert Pharmaceuticals, a biotechnology firm focusing on treatments for alopecia areata

Clinical studies have shown that minoxidil can effectively promote hair regrowth in individuals with alopecia areata, particularly in mild to moderate hair loss cases. Results may vary from person to person, and not everyone may respond to minoxidil treatment. To see the best results, it's also essential to use minoxidil consistently and as directed. This means applying it regularly to the affected areas of the scalp and continuing treatment even after hair regrowth occurs to maintain results.

Innovative Peptide Discovery by Lactocore Scientists Promises Breakthrough in Neurological Treatment

Lactocore, a US-German biotech startup founded by neuroscientists, has discovered a new, potentially safer, and more efficient way to treat depression, ADHD, and addictions.

Firstsource Acquires Quintessence

SaaS Security Innovator, AppOmni, Builds on Strong Financials, Customer Wins, Major Partnerships and Industry Awards to Expand Market Footprint in 2024

AppOmni, a SaaS security pioneer, experienced strong momentum during last fiscal year, including: ● Year-over-Year revenue growth of 116% ● 25% of Fortune 100 companies are customers ● More than 249 million users protected ● 38% employee growth ● 40% spike in deal registrations through channel partners

Cotiviti Completes Recapitalization with KKR and Long-Standing Owner Veritas

Particle Dynamics Appoints New CFO as it Advances its Strategic Growth Plans

One of the world’s leading oral solid dosage technology companies Particle Dynamics has announced a major new addition to its top team with the appointment of Mike Kanan as Chief Financial Officer.

Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device

First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable

FDB to Explore the Pharmacist's Role in Fitting a Patient's Genes to a Drug at NCPDP Annual Conference

https://www.prnewswire.com/news-releases/fdb-to-explore-the-pharmacists-role-in-fitting-a-patients-genes-to-a-drug-at-ncpdp-annual-conference-302134310.html?tc=eml_cleartime

Bioscript Group acquires Enzyme Communications to bolster its medical writing, scientific content creation and storytelling capabilities

Bioscript Group acquires Enzyme Communications

APM Steam Offers Unparalleled Heat Exchanger Assessment and Testing Services for Biopharmaceutical and Pharmaceutical Facilities

Ardena's Nanomedicines Facility Marks €20 Million Expansion with first GMP approval

Oss, The Netherlands: Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has received Good Manufacturing Practice (GMP) approval from the Dutch Healthcare Authority for its new analytical laboratories in its expanded nanomedicines facility.

CPHI North America experts ‘mid-sized domestic CDMOs need to invest in operational efficiencies to drive “real” reshoring’

Supply chain resilience and new partner sourcing to benefit from a boom in outsourcing in 2025

TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology

Lonza customers can now access TriLink’s CleanCap® mRNA capping technology for non-commercial use, enabling further development of critical mRNA therapeutics.